Li Xiang, Wang Yupeng, Gong Yiyi, Wu Yushuo, Pang Qianqian, Yu Wei, Wu Huanwen, Huo Li, Liu Yong, Jin Jin, Zhou Xi, Lv Wei, Zhou Lian, Xia Yu, Liu Wei, Chi Yue, Jiajue Ruizhi, Cui Lijia, Wang Ou, Xing Xiaoping, Jiang Yan, Li Mei, Xia Weibo
Department of Endocrinology, Key Laboratory of Endocrinology, National Commission of Health, State Key Laboratory of Complex Severe and Rare Diseases, Peking Union Medical College Hospital, Chinese Academy of Medical Sciences, Shuaifuyuan No. 1, Wangfujing Street, Dongcheng District, Beijing, 100730, China.
Department of Nuclear Medicine, Beijing Hospital, National Center of Gerontology, Institute of Geriatrics, Chinese Academy of Medical Sciences, Beijing, People's Republic of China.
Osteoporos Int. 2025 Sep 18. doi: 10.1007/s00198-025-07686-9.
This study presents a preoperative prediction model for tumor-induced osteomalacia (TIO) surgery outcomes on the basis of patient characteristics. The model, which was validated in 309 patients, identifies key risk factors and aids in clinical decision-making to optimize treatment strategies, reduce the number of unnecessary surgeries, and improve patient care.
Tumor-induced osteomalacia (TIO) should be curable by complete removal of the causative tumor. Knowledge of the prognosis of surgery is lacking. This study aimed to establish a prediction model that uses the preoperative characteristics of patients to predict the surgical treatment outcomes of patients with TIO.
This was a single-center, retrospective, case-control study. The main outcome was the surgical outcomes of patients with TIO. Patients with TIO who underwent surgical treatment were divided into a training set and a validation set. A nomogram was established in the training set, and the model was evaluated by the C-index, calibration curve, and clinical impact curve and verified in the validation set.
A total of 309 patients with TIO were included, with 222 in the training set and 87 in the validation set. The C-index of the nomogram was 0.864 (p < 0.001). The model had high goodness of fit-which is suggested by the calibration curve, and clinical benefit is indicated by the decision curve analysis and clinical impact curve. In the validation set, the area under the curve of the prediction model was 0.782 (p < 0.001), and decision curve analysis and clinical impact curve also suggested the existence of clinical benefit.
This study established a prognostic model for the preoperative prediction of surgical outcomes for TIO. This model can be used as a reference in clinical practice for the development of individualized treatment strategies.
本研究基于患者特征提出了一种用于肿瘤性骨软化症(TIO)手术结果的术前预测模型。该模型在309例患者中得到验证,可识别关键风险因素,并有助于临床决策,以优化治疗策略、减少不必要的手术数量并改善患者护理。
肿瘤性骨软化症(TIO)应通过彻底切除致病肿瘤得以治愈。目前缺乏关于手术预后的知识。本研究旨在建立一种利用患者术前特征来预测TIO患者手术治疗结果的预测模型。
这是一项单中心、回顾性、病例对照研究。主要结局是TIO患者的手术结果。接受手术治疗的TIO患者被分为训练集和验证集。在训练集中建立了列线图,并通过C指数、校准曲线和临床影响曲线对模型进行评估,并在验证集中进行验证。
共纳入309例TIO患者,其中训练集222例,验证集87例。列线图的C指数为0.864(p < 0.001)。校准曲线表明该模型具有良好的拟合优度,决策曲线分析和临床影响曲线表明具有临床益处。在验证集中,预测模型的曲线下面积为0.782(p < 0.001),决策曲线分析和临床影响曲线也表明存在临床益处。
本研究建立了一种用于术前预测TIO手术结果的预后模型。该模型可在临床实践中作为制定个体化治疗策略的参考。